Urgent.News

What's breaking now, across thousands of outlets.

Culture

Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future

Novo Nordisk’s chief executive, Mike Doustdar, is a year into a corporate turnaround. He says investors are still underestimating the promise of the company’s drugs.

Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future

We haven't written up this one. The New York Times has the full story — the link below goes straight to it.

Read the original at nytimes.com →

More in Culture

More from Tuesday 1 September →